16:18 EDT Kiora Pharmaceuticals (KPRX) files $100M mixed securities shelf
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KPRX:
- Kiora Pharmaceuticals Highlights at Ophthalmology Conference
- Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
- Kiora Pharmaceuticals Advances Retinal Disease Pipeline
- Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
- Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright